GENE ONLINE|News &
Opinion
Blog

Inflammatory Bowel Disease
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
Bora and Celltrion Join Forces To Distribute Oral Drugs Across APAC
2023-04-07
Bristol Myers Squibb’s Ulcerative Colitis Treatment Gains Further Validation
2022-10-25
Takeda Walks Away From Microbiome Deal With Finch
2022-08-29
Nestlé Lays Down €40 Million on Enterome’s Food Allergy and IBD Candidate
2022-07-19
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
Prometheus Bags $130 Million to Develop Precision Medicines for IBD Treatment
2020-11-10
Bristol Myers Squibb’s Zeposia Shines in Ulcerative Colitis Trial
2020-10-13
Boston Biotech, Alivio Receives Substantial Grant from U.S. DoD, a Second in Two Years
2020-10-08
Part II Highlights of BIO Asia-Taiwan 2020 (Day 1): Global Trends in Biotech and the Impact of COVID-19
2020-07-23Partner
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
R&D
Gilead, Second Genome Partner to Explore Microbial Biomarkers
2020-04-08
Gearing Towards a Microbiome Driven Therapy for Fighting Inflammatory Diseases
2020-03-20
LATEST
Crossing Borders for a New Era in Healthcare Quality: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
EVENT
Scroll to Top